Expanded Access Program for Radium-223 in Prostate Cancer

June 9, 2015
Oliver Sartor, MD

Oliver Sartor, MD, medical director, Tulane Cancer Center, discusses the United States experience of the Expanded Access Program (EAP) on radium-223 for prostate cancer.